DiabetologyNews.net

Diabetology Xagena

Xagena Mappa
Medical Meeting
XagenaNewsletter
Neurobase.it

An observational study has shown that patients with type 2 diabetes mellitus treated with a combination of Sitagliptin and Metformin initiated Insulin therapy at a slower rate during the period of obs ...


When patients with type 2 diabetes mellitus start their first injectable therapy, clinicians can choose between glucagon-like peptide-1 ( GLP-1 ) receptor agonists and basal insulins. In DURATION-3, ...


Although carbohydrate counting is the recommended dietary strategy for achieving glycaemic control in people with type 1 diabetes mellitus, the advice is based on narrative review and grading of the a ...


Previous studies have yielded conflicting results about the association between incretin therapies and acute pancreatitis. Researchers have compared the occurrence of acute pancreatitis in a populatio ...



Results from an observational study that has assessed the differences in time to initiation of Insulin use and the proportion of the population initiating Insulin among patients with type 2 diabetes t ...


The objective of a study was to evaluate the pharmacokinetics, efficacy and safety of Lixisenatide ( subcutaneous injection ) ( Lyxumia ) in elderly ( greater than or equal to 65 years old ) and very ...


Patients were twice as likely to have a diabetic foot ulcer heal within eight weeks when they were treated with a tissue repair drug versus a placebo, according to new research published in the Journa ...


Researchers have compared stepwise addition of bolus Insulin with a full basal-bolus regimen in patients with type 2 diabetes inadequately controlled on basal Insulin plus oral antidiabetic drugs. ...


Vitamin D is known as a major regulator of calcium levels and bone metabolism. Furthermore, it also influences the immune system. Previous studies have shown that patients with recently diagnosed type ...


The aim was to assess the efficacy and safety of Dapagliflozin ( Forxiga ) as add-on therapy in patients with type 2 diabetes who were inadequately controlled with a dipeptidyl peptidase-4 inhibitor w ...


Metformin ( Glucophage ) is the only first-line oral hypoglycaemic drug for type 2 diabetes recommended by international guidelines with proven efficacy, safety, and cost-effectiveness. However, littl ...


According to research published in Diabetologia, the journal of the European Association for the Study of Diabetes, people who have diabetes at the time they are diagnosed with cancer are more likely ...


New research published in Diabetologia, the journal of the European Association for the Study of Diabetes ( EASD ), has shown that diabetes mellitus in women is associated with an increased risk of st ...


Clinical trials have demonstrated that Metformin increases the efficiency of systemic therapy in cancer patients. Researchers examined whether the efficacy of conventional treatment of differentiat ...